Shahid S. Siddiqui, MS, PhD

Molecular biologist and developmental geneticist with over 40 years of experience. Founded McGenome in 2004. Has developed siRNA-based reagents, obtained international patents, and contributed to drug clinical trials in oncology and cardiovascular diseases.

Leads Myers Surgical Associates honing skills in both advanced surgical techniques and business management. At the National Board of Osteopathic Medical Examiners, her role melds healthcare leadership with a steadfast commitment to regulatory compliance and utilization management.

Has conducted phase three clinical studies demonstrating that plant stem cells in a proprietary vehicle were safe, tolerable, and significantly more beneficial in contributing superior clinical efficacy to treat various dermatological conditions and reverse aging.

Inspirational Medical Affairs Leader with 15 years of experience in Biological Sciences and over 10 years specifically in Hematology and Oncology. Provides strategic leadership for national Oncology Solid Tumor Teams, supporting multiple successful Immuno-oncology drug launches.

Distinguished researcher with 40 years studying Hedgehog signal transduction, which plays a central role in animal development and human disease. His contributions include identification of new pathway components and development of compounds to block Hedgehog signaling in cancer.

Drug development strategist with over 25 years of experience advancing therapeutics from discovery through late-stage clinical development. Founder of SS BioPharma Consulting, advising on cross-functional program execution.

Leads analytical, bioanalytical, and safety pharmacology studies across various models. Over 20 years of experience in designing pre-clinical GLP and non-GLP studies.

Accomplished leader with three decades of experience guiding drug development across small molecules, peptides, and biologics. Contributed to major regulatory milestones including filing several INDs at Bristol-Myers Squibb.

Possesses deep proficiency in the full life cycle of clinical development. Experienced leader with a proven history of high-quality medical writing, including complex clinical protocols and successful grant proposals.

Highly experienced molecular immunologist with research in pulmonary endothelial function and cell death pathway signaling. Has published in top-ranked peer-reviewed journals.